FDA gives Quidel nod on molecular respiratory viral test

03/13/2013 | GenomeWeb Daily News (free registration)

The FDA has given Quidel 510(k) clearance to sell its Molecular RSV + hMPV test, which is used to identify the presence of human metapneumovirus and respiratory syncytial virus as well as differentiate them from each other. The assay already is available for sale in Europe.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA